GRPH - Graphite Bio, Inc.
NasdaqGM - NasdaqGM Real-time price. Currency in USD
At close: 04:00PM EDT
After hours:
Stock chart is not supported by your current browser
| Previous close | 2.9200 |
| Open | 2.9400 |
| Bid | 2.9300 x 1000 |
| Ask | 3.0200 x 900 |
| Day's range | 2.8700 - 2.9700 |
| 52-week range | 1.5900 - 4.4800 |
| Volume | |
| Avg. volume | 132,482 |
| Market cap | 172.566M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Should You Buy Graphite Bio (GRPH) Ahead of Earnings?
Graphite Bio (GRPH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- Zacks
Down -39.59% in 4 Weeks, Here's Why Graphite Bio, Inc. (GRPH) Looks Ripe for a Turnaround
Graphite Bio, Inc. (GRPH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
